---
figid: PMC8541208__viruses-13-01892-g004
figtitle: 'Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the
  Orchestration of Carcinogenesis'
organisms:
- Human immunodeficiency virus 1
- Hepatitis B virus
- Human gammaherpesvirus 4
- Adenoviridae
- Human papillomavirus
- Human papillomavirus type 16
- Human gammaherpesvirus 8
- Human alphaherpesvirus 2
- Human papillomavirus types
- Merkel cell polyomavirus
- human papillomavirus 18
- Alphapapillomavirus 7
- human papillomavirus 11
- Deltapapillomavirus 4
- Bovine papillomavirus
- Human papillomavirus type 6
- Poliovirus 1
- Human papillomavirus type 6b
- Escherichia coli
- Helicobacter pylori
- Chlamydia trachomatis
- Mus musculus
- Rattus norvegicus
- Drosophila melanogaster
- Lareunionomyces loeiensis
- Allium cepa
- Schistosoma haematobium
- Homo sapiens
- NA
organisms_ner:
- Drosophila melanogaster
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Danio rerio
pmcid: PMC8541208
filename: viruses-13-01892-g004.jpg
figlink: /pmc/articles/PMC8541208/figure/viruses-13-01892-f004/
number: F4
caption: Evading growth suppressors. Unlike normal cells, where the growth and proliferation
  are tightly controlled, cells expressing HPV oncoproteins act to evade the key tumour
  suppressors pRB and p53. HPV-E7 can associate with pRB and inactivate the repressive
  function of the pRB/E2F transcription complex, leading to the expression of S-phase
  genes (cell cycle regulators, including cdc25a, cyclin E and A and replication enzymes
  and others) in otherwise cell cycle-exited and differentiating keratinocytes, leading
  to re-entry to the S phase. Further, high-risk E7 can downregulate pRB via proteasomal
  degradation via the cullin-2 ubiquitin ligase complex. HPV-16 E7 associates with
  cdk inhibitors p21Cip1 and p27Kip1, abrogates the inhibition of cdk2 activity and
  enhances the transcriptional activation of cdc25a, leading to the dephosphorylation
  of inhibitory phosphorylation in cdk-2/cyclin E/A. This leads to activation of the
  p53 tumour suppressor; however, high-risk E6 can inactivate and degrade p53 via
  the ubiquitin proteasome pathway involving the E6AP ubiquitin ligase complex. ub—ubiquitin
  and pp—2-25 residue peptides.
papertitle: 'The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins
  in the Orchestration of Carcinogenesis.'
reftext: Om Basukala, et al. Viruses. 2021 Oct;13(10):1892.
year: '2021'
doi: 10.3390/v13101892
journal_title: Viruses
journal_nlm_ta: Viruses
publisher_name: MDPI
keywords: HPV | viral oncoproteins | E5 | E6 | E7 | carcinogenesis
automl_pathway: 0.8504828
figid_alias: PMC8541208__F4
figtype: Figure
redirect_from: /figures/PMC8541208__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8541208__viruses-13-01892-g004.html
  '@type': Dataset
  description: Evading growth suppressors. Unlike normal cells, where the growth and
    proliferation are tightly controlled, cells expressing HPV oncoproteins act to
    evade the key tumour suppressors pRB and p53. HPV-E7 can associate with pRB and
    inactivate the repressive function of the pRB/E2F transcription complex, leading
    to the expression of S-phase genes (cell cycle regulators, including cdc25a, cyclin
    E and A and replication enzymes and others) in otherwise cell cycle-exited and
    differentiating keratinocytes, leading to re-entry to the S phase. Further, high-risk
    E7 can downregulate pRB via proteasomal degradation via the cullin-2 ubiquitin
    ligase complex. HPV-16 E7 associates with cdk inhibitors p21Cip1 and p27Kip1,
    abrogates the inhibition of cdk2 activity and enhances the transcriptional activation
    of cdc25a, leading to the dephosphorylation of inhibitory phosphorylation in cdk-2/cyclin
    E/A. This leads to activation of the p53 tumour suppressor; however, high-risk
    E6 can inactivate and degrade p53 via the ubiquitin proteasome pathway involving
    the E6AP ubiquitin ligase complex. ub—ubiquitin and pp—2-25 residue peptides.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - anon-70Dc
  - so
  - tt
  - DCTN6-p27
  - dap
  - CG9588
  - p53
  - betaTub60D
  - hth
  - LanB2
  - anon-70Db
  - Dp1
  - Dp
  - Aplip1
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - ebi
  - E2f2
  - E2f1
  - Rbf
  - Roc1a
  - Cul2
  - ppk
  - EloC
  - EloB
  - Go
  - CycE
  - cyc
  - pr
  - gb
  - Gbeta5
  - Gbeta13F
  - Gbeta76C
  - Cdc25a
  - Cdkn1b
  - Gabrg2
  - Dctn6
  - Psmd9
  - Cdkn1a
  - Nsg1
  - Tpt1
  - Tceal1
  - Trp53
  - Reep5
  - Tfdp1
  - Pgr
  - Rb1
  - Rbx1
  - Zer1
  - Eloc
  - Elob
  - CDC25A
  - CDKN1B
  - WARS1
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - TP53
  - TP63
  - TP73
  - UBE3A
  - PTGDR
  - TFDP1
  - REEP5
  - E2F1
  - E2F2
  - E2F3
  - E2F4
  - E2F5
  - E2F6
  - E2F7
  - E2F8
  - RB1
  - RBX1
  - GJB2
  - KLKB1
  - ZER1
  - ELOC
  - ELOB
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - SUCLG2
  - GNB1
  - GNB2
  - GNB3
  - GNB4
  - GNB5
  - Tmed7
  - Kras
  - Tp53
  - Tgm4
  - Ccne1
  - cdc25b
  - cdkn1a
  - tp53
  - rbx1
  - zer1
  - elob
---
